000 -LEADER |
fixed length control field |
02258nam a22004575i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140310153330.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
101118s2010 gw | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783642167584 |
|
978-3-642-16758-4 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS400-431 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Edition number |
23 |
264 #1 - |
-- |
Berlin, Heidelberg : |
-- |
Springer Berlin Heidelberg : |
-- |
Imprint: Springer, |
-- |
2010. |
912 ## - |
-- |
ZDB-2-CMS |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Dominguez, Celia. |
Relator term |
editor. |
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Neurodegenerative Diseases |
Medium |
[electronic resource] / |
Statement of responsibility, etc |
edited by Celia Dominguez. |
250 ## - EDITION STATEMENT |
Edition statement |
First. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XVII, 196 p. |
Other physical details |
online resource. |
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Topics in Medicinal Chemistry, |
International Standard Serial Number |
1862-2461 ; |
Volume number/sequential designation |
6 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach -- Phosphodiesterase Inhibition to Target the Synaptic Dysfunction in Alzheimer’s Disease -- Glutamate and Neurodegenerative Disease -- Modulation of the Kynurenine Pathway for the Potential Treatment of Neurodegenerative Diseases -- Spinal Muscular Atrophy: Current Therapeutic Strategies. |
520 ## - SUMMARY, ETC. |
Summary, etc |
The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach.- Phosphodiesterase Inhibition to Target the Synaptic Dysfunction in Alzheimer’s Disease.- Glutamate and Neurodegenerative Disease.- Modulation of the Kynurenine Pathway for the Potential Treatment of Neurodegenerative Diseases.- Spinal Muscular Atrophy: Current Therapeutic Strategies |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chemistry. |
|
Topical term or geographic name as entry element |
Toxicology. |
|
Topical term or geographic name as entry element |
Biochemistry. |
|
Topical term or geographic name as entry element |
Neurology. |
|
Topical term or geographic name as entry element |
Chemistry. |
|
Topical term or geographic name as entry element |
Medicinal Chemistry. |
|
Topical term or geographic name as entry element |
Neurology. |
|
Topical term or geographic name as entry element |
Pharmacology/Toxicology. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Printed edition: |
International Standard Book Number |
9783642167577 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-3-642-16758-4 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
E-Book |